Journal
FRONTIERS IN CHEMISTRY
Volume 11, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fchem.2023.1239467
Keywords
fingerprints; random forests; neglected diseases; classification; regression; graph neural networks
Categories
Ask authors/readers for more resources
Developing new drugs for disease treatment is challenging and requires multidisciplinary efforts, time, and resources. Machine learning approaches, specifically FP-MAP, are being used to improve the discovery of potential drugs and lead compounds. This study introduces a comprehensive atlas of fingerprint-based prediction models that cover a wide range of activities, including neglected tropical diseases and targets involved in diseases like Alzheimer's.
Discovering new drugs for disease treatment is challenging, requiring a multidisciplinary effort as well as time, and resources. With a view to improving hit discovery and lead compound identification, machine learning (ML) approaches are being increasingly used in the decision-making process. Although a number of ML-based studies have been published, most studies only report fragments of the wider range of bioactivities wherein each model typically focuses on a particular disease. This study introduces FP-MAP, an extensive atlas of fingerprint-based prediction models that covers a diverse range of activities including neglected tropical diseases (caused by viral, bacterial and parasitic pathogens) as well as other targets implicated in diseases such as Alzheimer's. To arrive at the best predictive models, performance of & AP;4,000 classification/regression models were evaluated on different bioactivity data sets using 12 different molecular fingerprints. The best performing models that achieved test set AUC values of 0.62-0.99 have been integrated into an easy-to-use graphical user interface that can be downloaded from https://gitlab.com/vishsoft/fpmap.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available